Envista (NVST) 2026 Global Healthcare Conference summary

Strategic overview and market performance

• Leadership joined over two years ago, focusing on leveraging strong assets and improving management for better financial results.

• Dental market rebounded post-COVID, with growth returning but not yet at 2019 levels; portfolio strength and new product development investments have driven share gains.

• Financial performance improved across the P&L, with balance sheet enhancements and consistent outperformance of long-term targets.

Segment and geographic trends

• Consumables outperform due to higher dental inflation and insulation from consumer sentiment, especially in the U.S. where private insurance dominates.

• Equipment and diagnostics rebounded after COVID-related contraction, with diagnostics currently the fastest-growing category due to innovation and easy comps.

• North America is the largest and fastest-growing market for core businesses, followed by Europe and developing markets; China lags due to VBP policy.

Pricing and inflation dynamics

• Company-wide pricing running at 1.8% in 2026, above long-term expectations due to external factors like tariffs and raw material costs.

• Long-term price increases expected to be 1–1.5% annually, with durable pricing power supported by market inflation trends.